En esta página
01MRKR precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
MRKR Marker Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 14, 2026
$1,05
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,84mínimo 52 semanas
$2,32máximo 52 semanas
Capitalización Bursátil (MRQ)
$18M
P/E
-1.3
BPA
$-0.79
Ingresos
$4M
tus insignias
Rango 52S
$1–$2
Calificación del Analista
BUY
Precio Objetivo
$8
P/E
-1.3
ROE
-89.1%
Margen de Beneficio Neto
-343.0%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
MRKR Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.05
Capitalización Bursátil (MRQ)
$18M
P/E
-1.3
BPA
$-0.79
Ingresos
$4M
ROE
-89.1%
Rango 52S
$1–$2
MRKR Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 27 de enero de 2023 | 1-for-10 | Inversa |
| 16 de septiembre de 2016 | 1-for-12 | Inversa |
| 25 de febrero de 2014 | 1-for-100 | Inversa |
| 27 de julio de 2009 | 1-for-10 | Inversa |
| 28 de junio de 2007 | 1-for-2 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$4M2017-12-31 → 2025-12-31
BPA$-0.792016-12-31 → 2025-12-31
Flujo de caja libre·2018-12-31 → 2019-12-31
Margen neto-343.0%2018-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | MRKR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -1.3promedio 5A ≈-2.6 | ≈-2.6 | · | · | |
| P/S | 4.9promedio 5A ≈133.8 | ≈133.8 | 7.4 | Infravalorado | |
| P/C (MRQ) | 1.4promedio 5A ≈5.2 | ≈5.2 | 2.0 | Valor razonable | |
| Price / Cash Flow (Precio / Flujo de Caja) | -1.5promedio 5A ≈-7.6 | ≈-7.6 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.0promedio 5A ≈5.2 | ≈5.2 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | MRKR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | -363.4%promedio 5A ≈-326.2% | ≈-326.2% | -541.8% | En línea | |
| EBITDA Margin (Margen EBITDA) | -363.4%promedio 5A ≈-318.4% | ≈-318.4% | -541.8% | En línea | |
| Pretax Margin (Margen antes de impuestos) | -343.4%promedio 5A ≈-309.8% | ≈-309.8% | -771.6% | De primer nivel | |
| Net Profit Margin (Margen de Beneficio Neto) | -343.0%promedio 5A ≈-271.6% | ≈-271.6% | -422.9% | En línea | |
| ROA | -59.2%promedio 5A ≈-55.6% | ≈-55.6% | -90.9% | De primer nivel | |
| ROE | -89.1%promedio 5A ≈-90.8% | ≈-90.8% | -195.2% | De primer nivel | |
| ROIC | -76.6%promedio 5A ≈-80.2% | ≈-80.2% | -71.4% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | MRKR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 6.0promedio 5A ≈5.2 | ≈5.2 | 1.7 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 7.1promedio 5A ≈4.5 | ≈4.5 | 2.8 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | MRKR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -46.2%promedio 5A ≈75.7% | ≈75.7% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 0.31%promedio 5A ≈54.2% | ≈54.2% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 48.0% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | MRKR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.2promedio 5A ≈0.2 | ≈0.2 | 0.2 | En línea | |
| Revenue / Employee (Ingresos / Empleado) | ≈$709.3K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
24.8%
Próximo informe
Nov 11, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 14, 2026 | $-0.09 | $-0.22 | 59.3% |
| 31 de marzo de 2026 | May 15, 2026 | $-0.16 | $-0.19 | 14.4% |
| 31 de diciembre de 2025 | $-0.09 | $-0.20 | 55.1% | |
| 30 de septiembre de 2025 | $-0.12 | $-0.46 | 73.9% | |
| 30 de junio de 2025 | $-0.29 | $-0.42 | 30.7% | |
| 31 de marzo de 2025 | $-0.36 | $-0.50 | 28.0% | |
| 31 de diciembre de 2024 | $-0.42 | $-0.22 | -87.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $7M | $3M | $4M | $1M | $500.0K | $213.2K | $206.0K | $183.1K | |
| R&D Expense | $12M | $13M | $10M | $12M | $28M | $19M | $13M | $8M | $5M | |
| SG&A Expense | $4M | $4M | $7M | $11M | $13M | $10M | $10M | $24M | $6M | |
| Operating Expenses | $16M | $18M | $18M | $23M | $41M | $29M | $23M | $148M | $12M | |
| Operating Income | $-13M | $-11M | $-15M | $-20M | $-39M | $-29M | $-23M | $-148M | $-11M | |
| Interest Income | $594.2K | $437.0K | $539.2K | $248.1K | $5.7K | $148.7K | $1M | $253.7K | $0 | |
| Pretax Income | $-12M | $-11M | $-14M | $-20M | · | · | · | · | · | |
| Income Tax | $-15.2K | $50.0K | $3.7K | · | · | · | · | $0 | $0 | |
| Net Income | $-12M | $-11M | $-8M | $-30M | $-42M | $-29M | $-21M | $-148M | $-11M | |
| EPS (Basic) | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 | $-0.61 | · | · | $-1.16 | |
| EPS (Diluted) | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 | $-0.61 | · | · | $-1.16 | |
| Shares (Basic) | 15,310,308 | 8,980,207 | 8,809,382 | 8,351,003 | 7,650,567 | 47,039,862 | 45,587,734 | 19,091,926 | 9,453,483 | |
| Shares (Diluted) | 15,310,308 | 8,980,207 | 8,809,382 | 8,351,003 | 7,650,567 | 47,039,862 | · | · | 9,453,483 | |
| EBITDA | $-13M | $-11M | $-15M | $-27M | $-37M | $-28M | $-22M | $-148M | $-12M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $19M | $15M | $12M | $42M | $21M | $44M | $62M | $5M | |
| Prepaid Expense | $658.8K | $483.7K | $988.1K | $2M | $2M | $2M | $2M | $141.7K | $51.1K | |
| Other Current Assets | · | $2.0K | · | · | · | · | · | · | · | |
| Current Assets | $19M | $22M | $17M | $17M | $46M | $24M | $45M | $62M | $5M | |
| PP&E (Net) | · | · | · | $12M | $12M | $10M | $418.0K | $147.7K | $0 | |
| PP&E (Gross) | · | · | · | $18M | $13M | $4M | $523.0K | $148.0K | $0 | |
| Accum. Depreciation | · | · | · | $5M | $3M | $591.0K | $105.0K | $0 | $0 | |
| Total Assets | $19M | $22M | $17M | $34M | $68M | $46M | $46M | $62M | $5M | |
| Accounts Payable | $793.7K | $1M | $961.0K | $1M | $5M | $3M | $993.0K | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | · | $5.0K | |
| Current Liabilities | $2M | $3M | $3M | $8M | $13M | $6M | $2M | $3M | $2M | |
| Capital Leases | · | · | · | $7M | $11M | $12M | $280.2K | $0 | · | |
| Total Liabilities | $2M | $3M | $3M | $15M | $24M | $18M | $2M | $3M | $2M | |
| Total Debt | · | · | · | · | · | · | · | · | $5.0K | |
| Common Stock | $16.7K | $10.7K | $8.9K | $8.4K | $8.3K | $50.7K | $45.7K | $45.4K | $10.6K | |
| Paid-in Capital | $476M | $466M | $450M | $448M | $442M | $384M | $372M | $365M | $161M | |
| Retained Earnings | $-459M | $-447M | $-436M | $-428M | $-398M | $-356M | $-328M | $-306M | $-157M | |
| Stockholders' Equity | $17M | $19M | $14M | $20M | $44M | $27M | $44M | $59M | $4M | |
| Liabilities + Equity | $19M | $22M | $17M | $34M | $68M | $46M | $46M | $62M | $5M | |
| Shares Outstanding | 16,700,000 | 10,700,000 | 8,900,000 | 8,400,000 | 8,300,000 | 50,700,000 | 45,700,000 | 45,400,000 | 10,600,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $3M | $2M | $485.6K | $105.1K | · | · | |
| Stock-based Comp | $537.5K | $245.9K | $858.3K | $3M | $6M | $5M | $5M | $16M | $3M | |
| Other Non-cash | · | · | · | $-5M | $6M | $4M | $-2M | · | · | |
| Operating Cash Flow | $-12M | $-11M | $-16M | $-27M | $-27M | $-20M | $-18M | $-14M | $-8M | |
| CapEx | · | · | · | · | · | · | $375.0K | $147.7K | $0 | |
| Investing Cash Flow | · | · | $19M | $-5M | $-3M | $-9M | $-375.0K | $-147.7K | $0 | |
| Stock Issued | $10M | $15M | $1M | $202.1K | $53M | $6M | $0 | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | $71.7K | $310.5K | |
| Net Stock Activity | $10M | · | $1M | $202.1K | $53M | $6M | · | $-71.7K | $-310.5K | |
| Financing Cash Flow | $10M | $15M | $1M | $202.1K | $53M | $7M | $816.5K | $71M | $6M | |
| Net Change in Cash | · | · | · | $12M | $44M | · | · | · | · | |
| Taxes Paid | $42.0K | $72.2K | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | $-19M | $-15M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -363.4% | -168.7% | -440.4% | -332.2% | · | -6188.2% | -10567.3% | -71930.1% | · | |
| Net Margin | -343.0% | -162.8% | -248.8% | -332.1% | · | -6149.7% | -10050.9% | -71826.3% | · | |
| Pretax Margin | -343.4% | -162.1% | -424.1% | · | · | · | · | · | · | |
| EBITDA Margin | -363.4% | -168.7% | -440.4% | -301.3% | · | -6084.2% | -10518.0% | -71930.1% | · | |
| ROA | -59.2% | -54.8% | -32.0% | -58.4% | -73.6% | -62.4% | -39.5% | -439.5% | -167.6% | |
| ROE | -89.1% | -82.5% | -53.6% | -141.8% | -87.0% | -99.1% | -46.6% | -492.9% | -223.2% | |
| ROIC | -76.6% | -60.2% | -103.8% | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 6.4 | 5.6 | 2.1 | 3.6 | 3.8 | 22.8 | 22.1 | 3.4 | |
| Quick Ratio | 7.1 | 5.5 | 4.9 | 1.5 | 3.3 | 3.3 | 22.0 | 22.0 | 3.4 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.01 | $1.73 | $1.58 | $2.33 | $0.53 | $0.54 | $0.96 | $1.31 | $0.35 | |
| Revenue / Share | $0.23 | $0.73 | $0.38 | $1.08 | $0.00 | · | · | · | · | |
| Cash Flow / Share | $-0.78 | $-1.21 | $-1.87 | $-3.23 | $-0.36 | · | · | · | $-0.89 | |
| Cash / Share | $0.96 | $1.79 | $1.70 | $1.40 | $0.51 | $0.42 | $0.96 | $1.36 | $0.48 | |
| EPS (TTM) | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 | $-0.61 | · | · | $-1.16 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -46.2% | 99.1% | -5.8% | 183.0% | 148.3% | · | · | · | · | |
| Revenue CAGR 3Y | 0.31% | 74.4% | 87.8% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 48.0% | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $7M | $3M | $4M | $1M | $500.0K | $213.2K | $206.0K | $183.1K | |
| Net Income TTM | $-12M | $-11M | $-8M | $-30M | $-42M | $-29M | $-21M | $-148M | $-11M | |
| Market Cap | $25M | $33M | $49M | $23M | $789M | $735M | $1.32B | $2.52B | $416M | |
| Enterprise Value | · | · | · | · | · | · | · | · | $410M | |
| P/E | -1.9 | -2.6 | -5.9 | -0.8 | -1.7 | -23.8 | · | · | -33.8 | |
| P/S | 7.0 | 5.0 | 14.8 | 6.5 | 635.8 | 1470.3 | 6173.5 | 12231.9 | 2269.8 | |
| P/B | 1.5 | 1.8 | 3.5 | 1.2 | 17.9 | 26.9 | 29.9 | 42.5 | 113.6 | |
| P / Tangible Book | 1.5 | 1.8 | 3.5 | 1.2 | 17.9 | 26.9 | · | · | · | |
| P / Cash Flow | -2.1 | -3.0 | -3.0 | -0.8 | -28.9 | -39.0 | -72.0 | -174.0 | -49.2 | |
| P / FCF | · | · | · | · | · | · | -70.5 | -172.3 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | -35.2 | |
| EV / Revenue | · | · | · | · | · | · | · | · | 2241.8 | |
| Earnings Yield | -53.0% | -38.3% | -17.1% | -132.6% | -57.6% | -4.2% | · | · | -3.0% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $751.7K | $1M | $1M | $861.2K | $349.1K | $2M | $2M | $1M | $1M | $1M | $257.6K | $762.7K | $1M | $759.1K | $999.6K | |
| R&D Expense | $1M | $3M | $2M | $2M | $4M | $3M | $5M | $3M | $2M | $3M | $3M | $2M | $2M | $3M | $-2M | $4M | |
| SG&A Expense | $1M | $1M | $846.6K | $1M | $945.2K | $1M | $1M | $854.7K | $1M | $1M | $1M | $1M | $3M | $2M | $1M | $3M | |
| Operating Expenses | $3M | $4M | $3M | $3M | $5M | $5M | $6M | $4M | $3M | $4M | $4M | $3M | $5M | $6M | $-339.6K | $7M | |
| Operating Income | $-3M | $-4M | $-2M | $-2M | $-5M | $-5M | $-4M | $-2M | $-2M | $-3M | $-3M | $-3M | $-4M | $-4M | $1M | $-6M | |
| Interest Income | $112.6K | $132.9K | $165.6K | $138.1K | $128.0K | $162.5K | $73.7K | $91.7K | $115.4K | $156.2K | $201.3K | $218.1K | $35.1K | $84.7K | $109.4K | $99.8K | |
| Net Income | $-2M | $-3M | $-2M | $-2M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-3M | $-3M | $3M | $-5M | $-4M | $-7M | |
| EPS (Basic) | $-0.09 | $-0.16 | $0.02 | $-0.12 | $-0.29 | $-0.40 | $-0.41 | $-0.26 | $-0.25 | $-0.27 | $-0.32 | $-0.34 | $0.29 | $-0.57 | $-0.45 | $-0.83 | |
| EPS (Diluted) | $-0.09 | $-0.16 | $0.02 | $-0.12 | $-0.29 | $-0.40 | $-0.41 | $-0.26 | $-0.25 | $-0.27 | $-0.32 | $-0.34 | $0.29 | $-0.57 | $-0.45 | $-0.83 | |
| Shares (Basic) | 19,314,742 | 19,314,742 | · | 16,757,678 | 13,956,562 | 11,106,027 | · | 8,923,170 | 8,918,233 | 8,901,962 | · | 8,825,881 | 8,798,956 | 8,721,031 | · | 8,359,920 | |
| Shares (Diluted) | 19,314,742 | 19,314,742 | · | 16,757,678 | 13,956,562 | 11,106,027 | · | 8,923,170 | 8,918,233 | 8,901,962 | · | 8,825,881 | 8,798,956 | 8,721,031 | · | 8,359,920 | |
| EBITDA | $-3M | $-4M | · | $-2M | $-4M | $-5M | · | $-2M | $-2M | $-3M | · | $-3M | $-4M | $-4M | · | $-7M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $15M | $16M | $18M | $10M | $14M | $19M | $9M | $8M | $11M | $15M | $17M | $18M | $6M | $12M | $18M | |
| Prepaid Expense | $1M | $418.1K | · | · | · | $841.3K | · | $1M | $1M | $917.0K | $988.1K | $2M | $2M | $2M | $2M | $3M | |
| Other Current Assets | $7.2K | $13.2K | · | · | · | · | $2.0K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $15M | $17M | $19M | $22M | $15M | $17M | $22M | $11M | $12M | $14M | $17M | $19M | $22M | $11M | $17M | $22M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $12M | · | $13M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $18M | · | $18M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | · | $5M | |
| Total Assets | $15M | $17M | $19M | $22M | $15M | $17M | $22M | $11M | $12M | $14M | $17M | $19M | $22M | $28M | $34M | $41M | |
| Accounts Payable | $585.0K | $2M | $793.7K | $951.0K | $2M | $1M | $1M | $2M | $1M | $1M | $961.0K | $1M | $1M | $3M | $1M | $2M | |
| Current Liabilities | $2M | $4M | $2M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $5M | $8M | $11M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | $7M | · | $7M | |
| Total Liabilities | $2M | $4M | $2M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $12M | $15M | $19M | |
| Common Stock | $16.7K | $16.7K | $16.7K | $16.7K | $11.3K | $11.2K | $10.7K | $8.9K | $8.9K | $8.9K | $8.9K | $8.9K | $8.8K | $8.8K | $8.4K | $83.6K | |
| Paid-in Capital | $476M | $476M | $476M | $476M | $466M | $466M | $466M | $451M | $451M | $450M | $450M | $450M | $450M | $449M | $448M | $447M | |
| Retained Earnings | $-464M | $-462M | $-459M | $-457M | $-455M | $-451M | $-447M | $-443M | $-441M | $-439M | $-436M | $-433M | $-431M | $-433M | $-428M | $-424M | |
| Stockholders' Equity | $12M | $14M | $17M | $18M | $10M | $14M | $19M | $7M | $10M | $12M | $14M | $17M | $19M | $16M | $20M | $23M | |
| Liabilities + Equity | $15M | $17M | $19M | $22M | $15M | $17M | $22M | $11M | $12M | $14M | $17M | $19M | $22M | $28M | $34M | $41M | |
| Shares Outstanding | 16,700,000 | 16,700,000 | 16,700,000 | 16,700,000 | 11,300,000 | 11,200,000 | 10,700,000 | 8,900,000 | 8,900,000 | 8,900,000 | 8,900,000 | 8,800,000 | 8,800,000 | 8,800,000 | 8,400,000 | 83,600,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | · | · | $818.2K | · | $819.9K | |
| Stock-based Comp | $195.7K | $178.4K | $111.1K | $33.3K | $14.0K | $379.1K | $50.5K | $53.3K | $62.6K | $79.4K | $143.4K | $175.0K | $-120.1K | $659.9K | $382.9K | $-210.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-4M | $-1M | $-2M | $-3M | $-2M | $-5M | $-5M | $1M | $-4M | $-4M | $-2M | $-1M | $-7M | $-6M | $-6M | $-8M | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $19M | $-112.6K | $-127.3K | $-99.4K | |
| Stock Issued | · | · | $0 | · | · | · | $15M | $0 | · | · | · | $394.7K | $0 | $620.0K | $138.6K | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $620.0K | · | · | |
| Financing Cash Flow | · | · | $0 | $10M | $100 | $505 | $15M | $1.7K | $44.6K | $49.1K | $5.1K | $479.3K | $736 | $620.0K | $138.6K | $0 |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -541.8% | · | -173.3% | -494.8% | -1320.1% | · | -124.6% | -197.4% | -204.9% | · | -1242.2% | -542.1% | -106.7% | · | -177.7% | |
| Net Margin | · | -422.9% | · | -162.1% | -466.3% | -1273.6% | · | -119.8% | -187.5% | -192.3% | · | -1157.6% | 329.9% | -104.9% | · | -175.2% | |
| EBITDA Margin | · | -541.8% | · | -173.3% | -494.8% | -1320.1% | · | -124.6% | -197.4% | -204.9% | · | -1242.2% | -542.1% | -89.4% | · | -177.7% | |
| ROA | -12.4% | -18.5% | · | -12.2% | -30.4% | -28.6% | · | -15.2% | -13.0% | -11.4% | · | -9.8% | 6.8% | -12.0% | · | -12.2% | |
| ROE | -16.1% | -22.5% | · | -15.5% | -39.8% | -33.8% | · | -19.1% | -15.3% | -17.3% | · | -15.2% | 10.7% | -19.2% | · | -18.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 4.8 | · | 6.5 | 3.5 | 6.8 | · | 3.2 | 5.9 | 6.1 | · | 7.0 | 7.5 | 2.1 | · | 2.0 | |
| Quick Ratio | 4.7 | 4.1 | · | 5.3 | 2.4 | 5.5 | · | 2.6 | 4.0 | 4.9 | · | 6.3 | 6.2 | 1.2 | · | 1.6 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.1 | · | 0.1 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.73 | $0.83 | · | $1.10 | $0.93 | $1.29 | · | $0.84 | $1.09 | $1.32 | · | $1.90 | $2.16 | $1.81 | · | $0.27 | |
| Revenue / Share | · | $0.04 | · | $0.07 | $0.06 | $0.03 | · | $0.22 | $0.13 | $0.14 | · | $0.03 | $0.09 | $0.54 | · | $0.05 | |
| Cash Flow / Share | · | $-0.07 | · | · | · | $-0.50 | · | · | · | $-0.43 | · | · | · | $-0.68 | · | · | |
| Cash / Share | $0.68 | $0.89 | · | $1.05 | $0.93 | $1.22 | · | $1.01 | $0.88 | $1.27 | · | $1.99 | $2.06 | $0.73 | · | $0.22 | |
| EPS (TTM) | $-0.35 | $-0.55 | · | $-1.22 | $-1.36 | $-1.32 | · | $-1.10 | $-1.18 | $-0.64 | · | $-1.07 | $-1.56 | $-2.96 | · | $-8.16 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | · | $5M | $5M | $6M | · | $5M | $4M | $3M | · | $3M | $4M | $4M | · | · | |
| Net Income TTM | $-9M | $-11M | · | $-14M | $-15M | $-13M | · | $-10M | $-10M | $-6M | · | $-9M | $-13M | $-25M | · | $-36M | |
| Market Cap | $25M | $22M | · | $15M | $17M | $14M | · | $25M | $48M | $38M | · | $40M | $27M | $6M | · | $309M | |
| P/E | -4.2 | -2.4 | · | -0.7 | -1.1 | -0.9 | · | -2.6 | -4.6 | -6.7 | · | -4.2 | -2.0 | -0.2 | · | -0.5 | |
| P/S | 6.2 | 5.5 | · | 3.2 | 3.2 | 2.4 | · | 4.7 | 13.0 | 11.5 | · | 13.3 | 7.3 | 1.7 | · | · | |
| P/B | 2.0 | 1.6 | · | 0.8 | 1.6 | 1.0 | · | 3.4 | 5.0 | 3.2 | · | 2.4 | 1.4 | 0.4 | · | 13.7 | |
| P / Tangible Book | 2.0 | 1.6 | · | 0.8 | 1.6 | 1.0 | · | 3.4 | 5.0 | 3.2 | · | 2.4 | 1.4 | 0.4 | · | 13.7 | |
| P / Cash Flow | · | -15.5 | · | · | · | -2.5 | · | · | · | -10.0 | · | · | · | -1.1 | · | · | |
| Earnings Yield | -23.8% | -42.3% | · | -137.1% | -88.9% | -107.3% | · | -39.0% | -21.7% | -14.9% | · | -23.6% | -50.3% | -416.9% | · | -220.5% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $4M | $7M | $3M | $4M | $1M |
| Margen Operativo % | -363.4% | -168.7% | -440.4% | -332.2% | · |
| Beneficio neto | $-12M | $-11M | $-8M | $-30M | $-42M |
| EPS Diluido | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 8.4 | 6.4 | 5.6 | 2.1 | 3.6 |
| Ratio Rápido | 7.1 | 5.5 | 4.9 | 1.5 | 3.3 |
No hay datos para este estado
Aún no hay suficientes datos fundamentales para generar este estado.
Propietarios institucionales (13F) 36 declarantes · $6.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
36
Valor en tenencia
$6.3M
Nuevas posiciones
4
Posiciones cerradas
4
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 4 (-3 vs trimestre anterior) | 4 (-3 vs trimestre anterior) | 6 (0 vs trimestre anterior) | 7 (-1 vs trimestre anterior) | +67K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| NEA Management Company, LLC | $2 389 747 | 1 625 678 | 37,73% | Acciones |
| Blue Owl Capital Holdings LP | $814 748 | 554 250 | 12,86% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $626 468 | 426 169 | 9,89% | Acciones |
| VANGUARD GROUP INC | $515 651 | 346 074 | 8,14% | Acciones |
| Aisling Capital Management LP | $478 293 | 325 370 | 7,55% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $366 652 | 249 423 | 5,79% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $205 558 | 139 816 | 3,25% | Acciones |
| OSAIC HOLDINGS, INC. | $165 590 | 112 649 | 2,61% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $128 285 | 87 269 | 2,03% | Acciones |
| LPL Financial LLC | $122 226 | 83 147 | 1,93% | Acciones |
| Concurrent Investment Advisors, LLC | $99 906 | 67 963 | 1,58% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $88 495 | 60 201 | 1,40% | Acciones |
| XTX Topco Ltd | $66 675 | 45 357 | 1,05% | Acciones |
| NORTHERN TRUST CORP | $50 905 | 34 629 | 0,80% | Acciones |
| CITADEL ADVISORS LLC | $47 800 | 32 517 | 0,75% | Acciones |
| STATE STREET CORP | $30 794 | 20 948 | 0,49% | Acciones |
| Invst, LLC | $26 460 | 18 000 | 0,42% | Acciones |
| Creative Planning | $25 449 | 17 312 | 0,40% | Acciones |
| JANE STREET GROUP, LLC | $24 743 | 16 832 | 0,39% | Acciones |
| Ashton Thomas Private Wealth, LLC | $24 108 | 16 400 | 0,38% | Acciones |
| FIFTH THIRD BANCORP | $14 700 | 10 000 | 0,23% | Acciones |
| UBS Group AG | $11 981 | 8 150 | 0,19% | Acciones |
| Vanguard Global Advisers, LLC | $3 693 | 2 512 | 0,06% | Acciones |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $2 900 | 2 000 | 0,05% | Acciones |
| Tower Research Capital LLC (TRC) | $1 191 | 810 | 0,02% | Acciones |
| WELLS FARGO & COMPANY/MN | $341 | 232 | 0,01% | Acciones |
| SIGNATUREFD, LLC | $335 | 228 | 0,01% | Acciones |
| SBI Securities Co., Ltd. | $298 | 203 | 0,00% | Acciones |
| GROUP ONE TRADING LLC | $262 | 178 | 0,00% | Acciones |
| Hilltop National Bank | $107 | 73 | 0,00% | Acciones |
| BARCLAYS PLC | $93 | 63 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $34 | 23 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $34 | 23 | 0,00% | Acciones |
| Virtu Financial LLC | $17 | 11 574 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $13 | 9 | 0,00% | Acciones |
| MORGAN STANLEY | $2 | 2 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 29 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×6 presentaciones | 17 de noviembre de 2025 | 9,90% | Enmienda | Inversión pasiva | SEC |
| John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 ×2 presentaciones | 20 de agosto de 2025 | 4,96% | Enmienda | · | SEC |
| Aisling Capital IV, LP, Aisling Capital Partners IV, LP, Aisling Capital Partners IV LLC, Steve Elms, Andrew Schiff | 3 de marzo de 2023 | · | Presentación inicial | · | SEC |
| Ann Leen ×2 presentaciones | 24 de marzo de 2021 | · | Presentación inicial | · | SEC |
| EASTERN CAPITAL LIMITED, PORTFOLIO SERVICES LTD., KENNETH B. DART ×14 presentaciones | 15 de marzo de 2021 | · | Presentación inicial | · | SEC |
| Juan Vera | 14 de febrero de 2019 | · | Presentación inicial | Inversión pasiva | SEC |
| John Robert Wilson | 14 de febrero de 2019 | · | Presentación inicial | Inversión pasiva | SEC |
| OR | 19 de octubre de 2018 | · | Presentación inicial | Inversión pasiva | SEC |
| Iroquois Master Fund Ltd., Iroquois Capital Management, LLC, Richard Abbe, Kimberly Page | 4 de abril de 2018 | · | Presentación inicial | Inversión pasiva | SEC |
| Sailesh C Barchha (2) | 27 de febrero de 2013 | · | Presentación inicial | · | SEC |
| Michael Gardner | 7 de enero de 2013 | · | Presentación inicial | Inversión pasiva | SEC |
| WILFRED A. JEFFERIES | 20 de julio de 2007 | · | Presentación inicial | Inversión pasiva | SEC |
| Persona informante no revelada | 3 de octubre de 2002 | · | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada | 20 de agosto de 2002 | · | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada, Persona informante no revelada | 26 de julio de 2002 | · | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada | 14 de mayo de 2002 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 14 de mayo de 2002 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 14 de mayo de 2002 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 14 de mayo de 2002 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 14 de mayo de 2002 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 14 de mayo de 2002 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 14 de mayo de 2002 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 13 de febrero de 2002 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 14 de mayo de 2001 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 14 de mayo de 2001 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 16 de abril de 2001 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 21 de marzo de 2001 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 21 de marzo de 2001 | · | Presentación inicial | · | SEC |
| Persona informante no revelada | 21 de marzo de 2001 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 37 insiders · 14 directivos · 18 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Juan Vera | Chief Executive Officer | 31 de octubre de 2025 A | 2 671 845 | 0 | 0 | $0 |
| Peter L. Hoang | President and CEO | 24 de marzo de 2022 F | 483 286 | 0 | 0 | $0 |
| Ronald L Handford | President/CEO | 16 de diciembre de 2003 A | · | 0 | 0 | $0 |
| Anthony H. Kim | Chief Financial Officer | 24 de marzo de 2022 F | 114 436 | 0 | 0 | $0 |
| Tracy A Moore | Chief Financial Officer | 14 de octubre de 2009 A | 500 000 | 0 | 0 | $0 |
| John N Bonfiglio | President and COO | 9 de marzo de 2017 A | 26 054 | 0 | 0 | $0 |
| Denis Corin | President | 17 de febrero de 2012 J | 2 394 535 | 0 | 0 | $0 |
| Anna Szymanska | Vice President, Quality | 27 de febrero de 2023 A | · | 0 | 0 | $0 |
| Nadia Agopyan | SVP, Regulatory Affairs | 27 de febrero de 2023 A | · | 0 | 0 | $0 |
| Mythili Koneru | Chief Medical Officer | 27 de febrero de 2023 A | · | 0 | 0 | $0 |
| Tsvetelina P Hoang | VP, Research and Development | 27 de febrero de 2023 A | · | 0 | 0 | $0 |
| Michael Loiacono | Chief Accounting Officer | 27 de febrero de 2023 A | · | 0 | 0 | $0 |
| Gerald Garrett | Vice President, Clinical Ops. | 17 de febrero de 2022 A | · | 0 | 0 | $0 |
| Wilfred Jefferies | Chief Scientist Officer | 16 de diciembre de 2003 A | · | 0 | 0 | $0 |
| Katharine Knobil | Consejero | 17 de noviembre de 2025 A | · | 0 | 0 | $0 |
| Steve Elms | Consejero | 17 de noviembre de 2025 A | 325 370 | 0 | 0 | $0 |
| Kathryn Penkus Corzo | Consejero | 31 de octubre de 2025 A | · | 0 | 0 | $0 |
| John Robert Wilson | Consejero | 6 de junio de 2023 A | 7 812 008 | 0 | 0 | $0 |
| David Laskow-Pooley | Consejero | 24 de mayo de 2022 A | 55 223 | 0 | 0 | $0 |
| Frederick Gerald Wasserman | Consejero | 8 de junio de 2021 A | 65 223 | 0 | 0 | $0 |
| Sherry Grisewood | Consejero | 16 de octubre de 2018 A | 19 582 | 0 | 0 | $0 |
| Mark Reddish | Consejero | 16 de octubre de 2018 A | 36 110 | 0 | 0 | $0 |
| Joshua Silverman | Consejero | 16 de octubre de 2018 A | 17 221 | 0 | 0 | $0 |
| Glynn Wilson | Consejero | 9 de octubre de 2018 M | 181 776 | 0 | 0 | $0 |
| Alan P Lindsay | Consejero | 11 de marzo de 2009 J | · | 0 | 0 | $0 |
| Carmen Chang | Propietario del 10% | 16 de marzo de 2021 P | 10 714 285 | 0 | 0 | $0 |
| Mohamad Makhzoumi | Propietario del 10% | 16 de marzo de 2021 P | 10 714 285 | 0 | 0 | $0 |
| Ali Behbahani | Propietario del 10% | 16 de marzo de 2021 P | 10 714 285 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | Propietario del 10% | 16 de marzo de 2021 P | 10 714 285 | 0 | 0 | $0 |
| Peter W. Sonsini | Propietario del 10% | 16 de marzo de 2021 P | 10 714 285 | 0 | 0 | $0 |
| Paul Walker | Propietario del 10% | 16 de marzo de 2021 P | 10 714 285 | 0 | 0 | $0 |
| Forest Baskett | Propietario del 10% | 16 de marzo de 2021 P | 10 714 285 | 0 | 0 | $0 |
| Scott D. Sandell | Propietario del 10% | 16 de marzo de 2021 P | 10 714 285 | 0 | 0 | $0 |
| Joshua Makower | Propietario del 10% | 16 de marzo de 2021 P | 10 714 285 | 0 | 0 | $0 |
| Norman David Eansor | · | 17 de noviembre de 2025 A | 7 142 | 0 | 0 | $0 |
| Grant R Atkins | · | 16 de diciembre de 2003 A | · | 0 | 0 | $0 |
| GENEMAX CORP | · | 16 de diciembre de 2003 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 2 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
MRKR Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 9 analistas
COMPRA
Objetivo mediano
$8.00
+661,9%
2 22,2%
Compra fuerte
6 66,7%
Compra
1 11,1%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
3 analistas · 2026-09-30Objetivo medio $7.87 +649,2%
← Por Debajo de Todos los Objetivos
Precio Actual $1.05
Mín$5.60
Media$7.87
Máx$10.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | · |
| DYAI | · | -4.1 | -11.6% | · | · | · |
| SHPH | $4M | -0.3 | 0.00% | · | -400.1% | · |
| NEUP | $24M | -1.4 | -92.5% | -1145.7% | -49.5% | · |
| KPTI | $135M | -0.4 | 0.57% | -134.2% | 73.7% | · |
| CLRB | · | -0.4 | · | · | · | · |
| ALLR | $17M | -0.0 | · | -3509.7% | -102.1% | · |
| PTN | $19M | -3.6 | -7.5% | -111.7% | -92.3% | · |
| KTTA | · | · | · | · | · | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 14, 2026